Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

Benzer Materyaller

• One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age
  Yazar:: Schwarz, Hans-Peter, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Long-term follow up of carbohydrate metabolism and adverse events after termination of Omnitrope® treatment in children born small for gestational age
  Yazar:: Walczak, Mieczyslaw, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data
  Yazar:: Romer, Tomasz, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• SUN-254 A Long-Term, Phase IV Study of Omnitrope®, a Recombinant Human Growth Hormone (rhGH), in Short Children Born Small for Gestational Age (SGA)
  Yazar:: Schwarz, Hans-Peter, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(®) in children requiring growth hormone treatment
  Yazar:: Pfäffle, Roland, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)